Company intelligence / Profile preview

BluePoint Laboratories

Cork, Munster, Ireland

Ownership: Private
Employees: ~31
Development stage: Other

Overview

BluePoint Laboratories markets high-quality generic drugs (mostly oral solids) across multiple indications, with FDA registrations and ongoing commercial supply in the US and EU. Products include antihypertensives, antidepressants, antineoplastics, antifungals, gastroenterology, and electrolyte agents with predictable inventory and a secure supply chain.

Therapeutic areas: NephrologyPsychiatryInfectious DiseasesGastroenterologyCardiovascularOncologyNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

American Health Packaging (exclusive US distributor for oral solids)Aurobindo USA (distribution partnership)Sourcing/manufacturing partnerships in China and India (Hefei Jingcheng Plastic Products, Nanjing 3h Medical Products, Lupin Limited, Aurobindo Pharma Limited)

Beyond the preview

Go deeper on BluePoint Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BluePoint Laboratories.

Explore the full profile